Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 248 | 7 | 317 | +76 |
| Shares | 122.6M | 8.98M | 124.8M | +11.2M (+9.8%) |
| Value | $4.95B | $362.6M | $6.56B | +$1.97B (+43.0%) |
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (131)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Showing the largest 100 of 131 by value.
Sold out (55)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
Not filed for Q1 2026 yet (7)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 5,523,948 | $223.2M |
| Capitolis Liquid Global Markets LLC | 3,045,200 | $123.0M |
| Norges Bank | 395,205 | $16.0M |
| CIBC World Markets Corp | 5,674 | $229.2K |
| CIBC Private Wealth Group, LLC | 5,000 | $202.0K |
| Comerica Bank | 105 | $4.24K |
| Global Retirement Partners, LLC | 1 | $40 |